Replies to post #450502 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Your scenario is and always was quite likely. Hard to say if Anavex could or would partner for one or both indication. Missling have the means to dilute and raise the funding, but at this stage as an investor I would be pleased to see a buyout or partnership.

[Hosai]

They prob would have diluted before RETT Excellence announcement when stock was hovering around $10 if they were worried about the cash.

[D-Mike]

I think they would immediately (if they haven’t already) pursue approval in Europe & Australia. Patients all over the World are screaming for an effective treatment and it appears we have the goods. The MAB’s aren’t the answer, those domino’s are falling now that Biobleed pulled Aduhelm.

[boi568]

You are overlooking the upcoming AD MAA in Europe which, if successful, will result in (a) a partnership and (b) cash flow in 2025.